Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Pretreatment Peripheral Circulating Lymphocyte CD4/CD8 Ratio in Patients with Non-metastatic Nasopharyngeal Carcinoma: a Multi-center Prospective Observational Study

NCT06762470 is registered in ClinicalTrials.gov with Jiangxi Provincial Cancer Hospital as lead sponsor.

NCT NCT06762470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06762470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Pretreatment Peripheral Circulating Lymphocyte CD4/CD8 Ratio in Patients with Non-metastatic Nasopharyngeal Carcinoma: a Multi-center Prospective Observational Study
Lead sponsor
Jiangxi Provincial Cancer Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2025
Completion date
December 31, 2029
Enrollment
325 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histopathological diagnosis of nasopharyngeal carcinoma, patients with nasopharyngeal carcinoma without distant metastases after ajcc/uacc 8th edition